Object Not Found. Please verify that the object you are linking to exists.

 

 

Resources

Images

Presentations

General Information on SCD

Useful Links

Discovery

About the Center

Center Personnel

Research Projects

Resources for Patients and Center Members

Center Training Programs

 

Contact UsSearchSite Map

 

Home >> Resources >> Publications and References

 


Publications and References

Reynolds Center Publications:

Lin S, Chakravarti A and Cutler DJ. Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies. Nature Genetics November 2004; 36: 1181-8.

Beg MF, Helm PA, McVeigh E, Miller MI and Winslow RL. Computational cardiac anatomy using MRI. Magnetic Resonance in Medicine November 2004; 52(5): 1167-74.

Spalwski I, Timothy K, Sharpe L, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz P, Joseph R, Condouris K, Tager-Flusberg H, Priori S, Sanguinetti M and Keating M. Cav1.2 Calcium channel dysfunction causes a mutlisystem disorder including arrhythmia and autism. Cell October 2004; 119(1): 19-31.

Lima JAC, Desai M, Steen H, Warren WP, Gautam S and Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation October 2004; 110(16): 2336-41.

Tomaselli GF and Zipes DP.  What causes sudden death in heart failure? Circulation Research October 2004; 95(8): 754-63.

Roguin A, Zviman M, Meininger G, Rodriquez ER, Dickfeld T, Bluemke D, Lardo A, Berger R, Calkins H and Halperin H. Modern pacemaker and implantable cardioverter-defibrillator systems can be MRI safe: In-vitro and in-vivo assessment of safety and function at 1.5-T. Circulation August 2004; 110(5):475-482.

Murata M, Cingolani E, McDonald A, Donahue JK and Marban E. Creation of a genetic calcium channel blocker by targeted gem gene transfer of the heart. Circulation Research August 2004; 95(4):398-405.

Osman NF and Prince JL. Regenerating MR tagged images using Harmonic Phase (HARP) methods. IEEE Trans Biomedical Engineering August 2004; 51:1428.

German D, d'Avignon C, Naiman DQ and Winslow RL. Classifying applications in genetics and molecular biology. Statistical Approaches in Genetics and Molecular Biology August 2004; 3(1): 19.

Ingwall JS and Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circulation Research July 2004; 95(2): 135-145.

Arking DE, Chugh SS, Chakravarti A and Spooner PM.  Genomics in sudden cardiac death. Circulation Research April 2004; 94(6): 712-23.

Wu KC and Lima JAC. Noninvasive imaging of myocardial viability: current techniques and future developments. Circulation Research December 2003; 93(12): 1146-1158.

References Cited on this website:

Schmermund A, Schwartz RS, Adamzik M, Sangiorgi G, Pfeifer EA, Rumberger JA, Burke AP, Farb A, Virmani R. Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with 'healthy' subjects dying out of hospital. Atherosclerosis 2001 Apr;155(2):499-508.

Kannel WB, McGee DL, Schatzkin A.An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study. Drugs 1984 Oct;28 Suppl 1:1-16.

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; The Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877-83.

Weiss JP, Saynina O, McDonald KM, McClellan MB, Hlatky MA. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries. Am J Med 2002 May;112(7):519-27.

Pacifico A, Ferlic LL, Cedillo-Salazar FR, Nasir N Jr, Doyle TK, Henry PD. Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 1999 Jul;34(1):204-10.

Hallstrom AP, McAnulty JH, Wilkoff BL, et al.; Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol 2001 Mar 15;37(4):1093-9.

Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr, Jouven X, Kuller LH, MacCluer JW, Marban E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, Zipes DP.Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001 May 15;103(19):2361-4.

Bigger JT. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002 Mar 21;346(12):931-3.

Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JL, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med.1996;335:1933-1940.

Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890. 

 

 

 

(C) 2004 The Johns Hopkins University  |  Site Disclaimer